• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Soligenix Launches Phase 2 Trial for SGX945 in Behçet`s Disease

    PR NEWSWIRE

    FDA Grants Soligenix "Fast Track" Designation for Dusquetide

    PRESS RELEASE

    Key Binding Characteristics of Dusquetide to Intracellular Protein Identified

    PRNEWSWIRE

    Dusquetide Shows +ve Anti-tumor Efficacy in Multiple Nonclinical Animal Studies

    PRNEWSWIRE

    Soligenix completes enrollment in phase 3 DOM-INNATE trial of SGX942

    PHARMABIZ

    Soligenix Completes Enrollment in its Pivotal Ph 3 Trial of SGX942

    PRNEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.